Analyst Ratings for Exact Sciences
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Exact Sciences (NASDAQ:EXAS) in the last quarter, with 10 bullish, 1 somewhat bullish, and 2 indifferent ratings. The company has an average 12-month price target of $103.77, which has increased by 16.86% over the past month.
August 08, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exact Sciences received mostly bullish ratings from analysts in the last quarter. The average 12-month price target is $103.77, up 16.86% over the past month.
The bullish ratings and increased price target indicate a positive outlook for Exact Sciences. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100